Yin Ran, Kuo Hsiao-Chen, Hudlikar Rasika, Sargsyan Davit, Li Shanyi, Wang Lujing, Wu Renyi, Kong Ah-Ng
Department of Pharmaceutics, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, NJ 08854, USA.
Graduate Program in Pharmaceutical Science, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, NJ 08854, USA.
Curr Pharmacol Rep. 2019;5:332-344. doi: 10.1007/s40495-019-00196-3. Epub 2019 Aug 19.
In this review, we discuss the roles of the gut microbiota, dietary phytochemicals in improving human health. Recent studies have reported that the human gut microbiota can be altered by dietary phytochemicals including phenolics, carotenoids, and dietary fibers. In addition, both pathogenic and nonpathogenic bacteria show regulatory effects with phytochemicals, suggesting potential synergistic effects in the improvement of human gut health and prevention of chronic diseases.
Numerous studies have been conducted on gut microbial alterations induced by phytochemicals, such as phenolics and carotenoids. Butyrate, a short-chain fatty acid produced via bacterial fermentation in the colon, also shows a significantly beneficial effect in the maintenance of gut microbial homeostasis. However, the molecular mechanisms underlying the effects of diets and the interactions of the gut microorganisms remain poorly understood. The gut microbiome profile changes have been observed in chronic inflammation-induced diseases including colitis, Crohn's disease, immune dysfunction, colon cancer, obesity and diabetes. The anti-inflammatory effects of dietary phytochemicals against these diseases may be partially mediated by regulation of microbial profiles. Latest advances in biomedical technology such as the next-generation sequencing (NGS), and continuous cost reduction associated with these technologies, enabled researchers to perform ever-increasing number of large-scale, high-throughput computational analyses to elucidate the potential mechanism of phytochemical-microbiome interactions.
Information obtained from these studies may provide valuable insights to guide future clinical research for the development of therapeutics, botanicals and drug efficacy testing, many of which will be discussed in this review.
在本综述中,我们讨论肠道微生物群、膳食植物化学物质在改善人类健康方面的作用。最近的研究报告称,膳食植物化学物质,包括酚类、类胡萝卜素和膳食纤维,可以改变人类肠道微生物群。此外,致病性和非致病性细菌都对植物化学物质表现出调节作用,这表明在改善人类肠道健康和预防慢性病方面可能存在潜在的协同效应。
已经对植物化学物质(如酚类和类胡萝卜素)引起的肠道微生物变化进行了大量研究。丁酸盐是结肠中细菌发酵产生的一种短链脂肪酸,在维持肠道微生物稳态方面也显示出显著的有益作用。然而,饮食作用的分子机制以及肠道微生物之间的相互作用仍知之甚少。在包括结肠炎、克罗恩病、免疫功能障碍、结肠癌、肥胖症和糖尿病在内的慢性炎症性疾病中,观察到了肠道微生物组谱的变化。膳食植物化学物质对这些疾病的抗炎作用可能部分是通过调节微生物谱来介导的。生物医学技术的最新进展,如下一代测序(NGS),以及与这些技术相关的持续成本降低,使研究人员能够进行越来越多的大规模、高通量计算分析,以阐明植物化学物质与微生物组相互作用的潜在机制。
从这些研究中获得的信息可能为指导未来的临床研究提供有价值的见解,以开发治疗方法、植物药和药物疗效测试,其中许多将在本综述中进行讨论。